Literature DB >> 23448476

Opioid receptor interacting proteins and the control of opioid signaling.

Jennifer T Lamberts, John R Traynor1.   

Abstract

Opioid receptors are seven-transmembrane domain receptors that couple to intracellular signaling molecules by activating heterotrimeric G proteins. However, the receptor and G protein do not function in isolation but their activities are modulated by several accessory and scaffolding proteins. Examples include arrestins, kinases, and regulators of G protein signaling proteins. Accessory proteins contribute to the observed potency and efficacy of agonists, but also to the direction of signaling and the phenomenon of biased agonism. This review will present current knowledge of such proteins and how they may provide targets for future drug design.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448476      PMCID: PMC6707067          DOI: 10.2174/138161281942140105160625

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

Review 1.  The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Authors:  Paul Klenowski; Michael Morgan; Selena E Bartlett
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 2.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

3.  Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif.

Authors:  Kevin J Frankowski; Stephen R Slauson; Kimberly M Lovell; Angela M Phillips; John M Streicher; Lei Zhou; David A Whipple; Frank J Schoenen; Thomas E Prisinzano; Laura M Bohn; Jeffrey Aubé
Journal:  Bioorg Med Chem       Date:  2014-12-23       Impact factor: 3.641

Review 4.  Delta Opioid Receptor Expression and Function in Primary Afferent Somatosensory Neurons.

Authors:  Amaury François; Grégory Scherrer
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Nanoscale effects of ethanol and naltrexone on protein organization in the plasma membrane studied by photoactivated localization microscopy (PALM).

Authors:  Steven J Tobin; Eliedonna E Cacao; Daniel Wing Wo Hong; Lars Terenius; Vladana Vukojevic; Tijana Jovanovic-Talisman
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

Review 6.  Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management.

Authors:  Nicolas B Senese; Ram Kandasamy; Kelsey E Kochan; John R Traynor
Journal:  Front Mol Neurosci       Date:  2020-01-24       Impact factor: 5.639

7.  Chronic paternal morphine exposure increases sensitivity to morphine-derived pain relief in male progeny.

Authors:  Andre B Toussaint; William Foster; Jessica M Jones; Samuel Kaufmann; Meghan Wachira; Robert Hughes; Angela R Bongiovanni; Sydney T Famularo; Benjamin P Dunham; Ryan Schwark; Reza Karbalaei; Carmen Dressler; Charlotte C Bavley; Nathan T Fried; Mathieu E Wimmer; Ishmail Abdus-Saboor
Journal:  Sci Adv       Date:  2022-02-16       Impact factor: 14.136

8.  Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2.

Authors:  D Malfacini; C Ambrosio; M C Gro'; M Sbraccia; C Trapella; R Guerrini; M Bonora; P Pinton; T Costa; G Calo'
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

9.  Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid Receptor.

Authors:  Xiaojing Cong; Pablo Campomanes; Achim Kless; Inga Schapitz; Markus Wagener; Thomas Koch; Paolo Carloni
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.